Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications

The introduction of DPP-4 inhibitors substantially increased therapeutic options for type 2 diabetes mellitus (T2DM). The unique mechanism of action allows using these agents both as monotherapy and in combination with conventional anti-diabetes drugs. Evidence base for efficacy and safety of DPP-4...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Elena Valer'evna Biryukova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2014
Materias:	diabetes mellitus dpp-4 inhibitors incretins vildagliptin Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/8c30a6a6702c497f943e2333951c8c6a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8c30a6a6702c497f943e2333951c8c6a
record_format	dspace
spelling	oai:doaj.org-article:8c30a6a6702c497f943e2333951c8c6a2021-11-14T09:00:18ZClinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications2072-03512072-037810.14341/DM2014181-84https://doaj.org/article/8c30a6a6702c497f943e2333951c8c6a2014-03-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/6303https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378The introduction of DPP-4 inhibitors substantially increased therapeutic options for type 2 diabetes mellitus (T2DM). The unique mechanism of action allows using these agents both as monotherapy and in combination with conventional anti-diabetes drugs. Evidence base for efficacy and safety of DPP-4 inhibitors deepens every year, but to date only a few studies addressed direct comparison between individual agents within this pharmacological class. Current article presents data from the studies comparing vildagliptin with other DPP-4 inhibitors, as well as GLP-1 agonists.Elena Valer'evna BiryukovaEndocrinology Research Centrearticlediabetes mellitusdpp-4 inhibitorsincretinsvildagliptinNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 17, Iss 1, Pp 81-84 (2014)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	diabetes mellitus dpp-4 inhibitors incretins vildagliptin Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	diabetes mellitus dpp-4 inhibitors incretins vildagliptin Nutritional diseases. Deficiency diseases RC620-627 Elena Valer'evna Biryukova Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications
description	The introduction of DPP-4 inhibitors substantially increased therapeutic options for type 2 diabetes mellitus (T2DM). The unique mechanism of action allows using these agents both as monotherapy and in combination with conventional anti-diabetes drugs. Evidence base for efficacy and safety of DPP-4 inhibitors deepens every year, but to date only a few studies addressed direct comparison between individual agents within this pharmacological class. Current article presents data from the studies comparing vildagliptin with other DPP-4 inhibitors, as well as GLP-1 agonists.
format	article
author	Elena Valer'evna Biryukova
author_facet	Elena Valer'evna Biryukova
author_sort	Elena Valer'evna Biryukova
title	Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications
title_short	Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications
title_full	Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications
title_fullStr	Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications
title_full_unstemmed	Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications
title_sort	clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications
publisher	Endocrinology Research Centre
publishDate	2014
url	https://doaj.org/article/8c30a6a6702c497f943e2333951c8c6a
work_keys_str_mv	AT elenavalerevnabiryukova clinicalimplementetionofvildagliptindatafromrecentstudiescomparingincretinbasedmedications
_version_	1718429592108138496

Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications

Ejemplares similares